TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical

          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development

          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences

          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations

          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting

          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval

          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting

          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance

          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access

          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services

          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management

          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems

          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management

          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise

          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services

          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > News & Events

News & Events

Integrated Product Development for new osteoarthritis treatments

Integrated Product Development for new osteoarthritis treatments

July 28th, 2022
09:00 AM CET

2022 RAPS Convergence, Phoenix, USA – 11 to 13 September 2022

2022 RAPS Convergence, Phoenix, USA – 11 to 13 September 2022

September 11 - 13th, 2022
Visit us at booth 507

The regulatory and business importance of medical device post-market surveillance

The regulatory and business importance of medical device post-market surveillance

July 28th, 2022
09:00 AM CET

DIA 2022 – Reconnect with Your Life Sciences Community Live in Chicago

DIA 2022 – Reconnect with Your Life Sciences Community Live in Chicago

June 19 - 23rd, 2022
Visit us at booth #1515

PDA Ireland: Data Integrity

PDA Ireland: Data Integrity

June 23rd, 2022

NLS DAYS 2022

NLS DAYS 2022

September 28 - May 29th, 2022
Visit us at booth X51

PharmaLex expands pricing & reimbursement and health economics platform with EBMA Consulting merger

PharmaLex expands pricing & reimbursement and health economics platform with EBMA Consulting merger

9th March 2022

PharmaLex extends reach to Japan, East Asia and Southeast Asia with Ascent Development Services merger

PharmaLex extends reach to Japan, East Asia and Southeast Asia with Ascent Development Services merger

8th February 2022

PharmaLex expands global footprint capabilities for clinical and regulatory services with Phlexglobal merger

PharmaLex expands global footprint capabilities for clinical and regulatory services with Phlexglobal merger

25th January 2022

PharmaLex merger with MAP Group expands integrated market access expertise

PharmaLex merger with MAP Group expands integrated market access expertise

18th January 2022

Pharma time-to-market reduced thanks to more efficient submission document publishing services

Pharma time-to-market reduced thanks to more efficient submission document publishing services

11th January 2022

PharmaLex extends footprint for technology-enabled smart services with new strategic partnership

PharmaLex extends footprint for technology-enabled smart services with new strategic partnership

7th December 2021

PharmaLex expands technology-enabled solution portfolio with integration of software platforms

PharmaLex expands technology-enabled solution portfolio with integration of software platforms

30th November 2021

Points de vigilance vis-à-vis de la communication institutionnelle en France

Points de vigilance vis-à-vis de la communication institutionnelle en France

23rd November 2021

Pharmalex Launches Biopharma Excellence Brand, with Ex-MHRA Scientific Lead Dr. Christian K. Schneider at the Helm

Pharmalex Launches Biopharma Excellence Brand, with Ex-MHRA Scientific Lead Dr. Christian K. Schneider at the Helm

13th October 2021

Recent changes in Australia for COVID-19 Rapid Antigen Self-Tests

Recent changes in Australia for COVID-19 Rapid Antigen Self-Tests

30th September 2021

PharmaLex with its own panel at Biotech Atelier 2021 Conference

PharmaLex with its own panel at Biotech Atelier 2021 Conference

24th September 2021

PharmaLex expands IT consulting and system integration expertise for the Life Science industry

PharmaLex expands IT consulting and system integration expertise for the Life Science industry

14th September 2021

PharmaLex participates in Inno4vac

PharmaLex participates in Inno4vac

24th August 2021

At Last Digital Transformation is Embraced by the Healthcare Industry

At Last Digital Transformation is Embraced by the Healthcare Industry

19th August 2021

PharmaLex Global Statistics and Data Science Team announced as winner by BookAuthority

PharmaLex Global Statistics and Data Science Team announced as winner by BookAuthority

16th August 2021

Data Compliance or Rejection – Are you ready for September 15th?

Data Compliance or Rejection – Are you ready for September 15th?

9th August 2021

Signal Detection

Signal Detection

16th July 2021

Log or not log (transform data) that’s the question

Log or not log (transform data) that’s the question

1st July 2021

Data Science on Blockchain with R. Part I: Reading the blockchain

Data Science on Blockchain with R. Part I: Reading the blockchain

23rd June 2021

Enoval et les laboratoires accrédités

Enoval et les laboratoires accrédités

7th June 2021

PharmaLex broadens market access and HEOR reach

PharmaLex broadens market access and HEOR reach

4th June 2021

Resilience of Pharma Supply Chains and the Impact of Covid-19 Pandemic

Resilience of Pharma Supply Chains and the Impact of Covid-19 Pandemic

17th May 2021

PharmaLex expands APAC region

PharmaLex expands APAC region

23rd April 2021

Contamination Control

Contamination Control

8th April 2021
Upcoming Events

September 11 - 13th, 2022

2022 RAPS Convergence, Phoenix, USA – 11 to 13 September 2022

Visit us at booth 507

Recent News
  • CONSIDERATIONS FOR A VALUE-ADDED INTERNAL AUDIT PROGRAM
    28th July 2022
  • Why collaboration and an Integrated Product Development program are key to successful drug development
    14th June 2022
  • Key Takeaways from the PDA Europe Annex 1 Workshop
    7th June 2022
  • Sponsors gear up for a smoother process with CTIS but must first overcome key hurdles
    2nd June 2022
  • Medical device software brings new complications around compliance
    30th May 2022
  • Addressing Limitations of Sterility Testing
    9th May 2022
Categories
  • All News
  • Webinars
  • Events
Archive
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
pharmalexglobal PharmaLex @pharmalexglobal ·
5h

Join our webinar to learn more about 👉 Integrated product development for new osteoarthritis treatments on September 20, 4-5 PM CET

Register now: https://go.pharmalex.com/pharmalex-webinar-integrated-product-development-osetoarthritis-treatments?utm_source=SocialMedia&utm_medium=Webinar&utm_campaign=IPD

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY

  • Worked with us and our contractors to help us achieve our tight targets, operate with our systems and procedures and are considered invaluable part of our team

    US based large development group
    VP Regulatory / Quality
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for